These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10784544)

  • 1. Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice.
    Mann RD; Pearce GL; Dunn N; Shakir S
    BMJ; 2000 Apr; 320(7243):1184-6. PubMed ID: 10784544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of non-sedating antihistamines.
    Lindquist M; Edwards IR
    Lancet; 1997 May; 349(9061):1322. PubMed ID: 9142080
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.
    de Abajo FJ; Rodríguez LA
    Br J Clin Pharmacol; 1999 Mar; 47(3):307-13. PubMed ID: 10215756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.
    Layton D; Wilton L; Boshier A; Cornelius V; Harris S; Shakir SA
    Drug Saf; 2006; 29(10):897-909. PubMed ID: 16970513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of second generation antihistamines.
    Philpot EE
    Allergy Asthma Proc; 2000; 21(1):15-20. PubMed ID: 10748947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations among non-sedating antihistamines: are there real differences?
    Mattila MJ; Paakkari I
    Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine.
    Ballmer-Weber BK; Gex-Collet C; Wüthrich B
    J Investig Allergol Clin Immunol; 1999; 9(6):351-5. PubMed ID: 10664928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
    Delgado LF; Pferferman A; Solé D; Naspitz CK
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antihistamines with varying anticholinergic properties on voluntary and involuntary movement.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Kavanagh JJ
    Clin Neurophysiol; 2013 Sep; 124(9):1840-5. PubMed ID: 23643576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity of new antihistamines and cisapride.
    Paakkari I
    Toxicol Lett; 2002 Feb; 127(1-3):279-84. PubMed ID: 12052668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sedation from H1 antagonists: evaluation methods and experimental results.
    Passalacqua G; Scordamaglia A; Ruffoni S; Parodi MN; Canonica GW
    Allergol Immunopathol (Madr); 1993; 21(2):79-83. PubMed ID: 8101691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis.
    Spangler DL; Brunton S
    South Med J; 2006 Jun; 99(6):593-9. PubMed ID: 16800414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
    Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic overview of oral second-generation H1 antihistamines.
    González MA; Estes KS
    Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94.
    O'Hanlon JF; Ramaekers JG
    Allergy; 1995 Mar; 50(3):234-42. PubMed ID: 7677241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dangers of non-sedating antihistamines.
    Cohen AT
    Lancet; 1997 Jul; 350(9070):69; author reply 69-70. PubMed ID: 9217740
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety profile of H1-antihistamines in pediatrics: an analysis based on data from VigiBase.
    Motola D; Donati M; Biagi C; Calamelli E; Cipriani F; Melis M; Monaco L; Vaccheri A; Ricci G
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1164-1171. PubMed ID: 28653802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
    Roongapinun S; Wajajamreon S; Fooanant S
    J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central nervous system effects of H1-receptor antagonists in the elderly.
    Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine.
    Glass DJ; Harper AS
    BMC Fam Pract; 2003 Aug; 4():10. PubMed ID: 12917016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.